Cargando…
A Short-Term Effect of Low-Dose Aspirin on Major Hemorrhagic Risks in Primary Prevention: A Case-Crossover Design
BACKGROUND: Very few studies have examined the risk of short-term adverse hemorrhage of low-dose aspirin use in primary prevention. This case-crossover study examined the transient effect of low-dose aspirin use on major hemorrhagic risks. METHODS: A representative database of 1,000,000 patients ran...
Autores principales: | Wu, I-Chen, Lin, Ming-Yen, Yu, Fang-Jung, Hsieh, Hui-Min, Chiu, Kuei-Fen, Wu, Ming-Tsang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039487/ https://www.ncbi.nlm.nih.gov/pubmed/24879431 http://dx.doi.org/10.1371/journal.pone.0098326 |
Ejemplares similares
-
A short-term risk–benefit analysis of occasional and regular use of low-dose aspirin in primary prevention of vascular diseases: a nationwide population-based study
por: Wu, I-Chen, et al.
Publicado: (2015) -
Analysis of the Occurrence of Major Hemorrhagic Incidents in Patients with Low-Dose Aspirin Usage in Korean Populations – Does Low-Dose Aspirin Really Increase the Risk of Bleeding?
por: Kim, Tae Gon, et al.
Publicado: (2020) -
Daily Aspirin Reduced the Incidence of Hepatocellular Carcinoma and Overall Mortality in Patients with Cirrhosis
por: Lee, Chern-Horng, et al.
Publicado: (2023) -
The outcome of short-term low-dose aspirin treatment in Kawasaki disease based on inflammatory markers
por: Yoo, Jae Won, et al.
Publicado: (2017) -
Low-Dose Aspirin for the Primary Prevention of Cardiovascular Disease in Diabetic Individuals: A Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis
por: Lin, Ming-Hsun, et al.
Publicado: (2019)